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e 11, 2013.he objective of our study was to review the long-term outcomes of patients undergoing surgical repair of
aortic coarctation.Background Surgical repair of aortic coarctation has been performed at the Mayo Clinic, Rochester, Minnesota, for over 60 years.Methods Between 1946 and 2005, 819 patients with isolated coarctation of the aorta underwent primary operative repair.
Medical records were reviewed and questionnaires mailed to the patients.Results Mean age at repair was 17.2  13.6 years. The majority (83%) had pre-operative hypertension. Operations included
simple and extended end-to-end anastomosis (n ¼ 632), patch angioplasty (n ¼ 72), interposition grafting (n ¼ 49),
bypass grafting (n ¼ 30), and subclavian ﬂap or “other” (n ¼ 35). Overall early mortality (<30 days) was 2.4%. In the
previous 30 years (n ¼ 225), there were no operative deaths. Mean follow-up was 17.4  13.9 years, with
a maximum of 59.3 years. Actuarial survival rates were 93.3%, 86.4%, and 73.5% at 10, 20, and 30 years,
respectively. When compared to an age- and sex-matched population, long-term survival was decreased (p < 0.001).
Older age at repair (>20 yrs) and pre-operative hypertension were associated with decreased survival (p < 0.001).
Patients age <9 years age at repair had signiﬁcantly less hypertension at 5 to 15 years of follow-up (p < 0.001).
Rates of freedom from re-intervention on the descending aorta were 96.7%, 92.2%, and 89.4% at 10, 20, and 30
years, respectively. Younger age at time of repair (p < 0.001) and an end-to-end anastomosis technique (p < 0.001)
were independently associated with lower rates of re-intervention on the descending aorta.Conclusions Primary repair of isolated coarctation of the aorta was performed with a low rate of mortality. However, long-term
survival was reduced compared with that in an age- and sex-matched population, and many patients required further
reoperation. These ﬁndings emphasize that patients with aortic coarctation need early recognition and intervention,
as well as lifelong informed follow-up. (J Am Coll Cardiol 2013;62:1020–5) ª 2013 by the American College of
Cardiology FoundationAortic coarctation is deﬁned as a narrowed aortic segment,
most commonly located near the ligamentum arteriosum
adjacent to the left subclavian artery (1). It can be discrete,
long, or complex, involving the aortic arch or isthmus, and
may have collateral vessels (1). Coarctation of the aorta has
an estimated incidence of 1 in 2,500 live births, with a 2:1
predominance in males (2,3). In historical series, untreated
aortic coarctation led to a mortality of more than 80% by age
50 years due to complications including aortic rupture, heart
failure, and intracranial hemorrhage (4).Surgery, Mayo Clinic, Rochester, Minnesota;
Mayo Clinic, Rochester, Minnesota; zDivision
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013; revised manuscript received May 20, 2013,The ﬁrst successful repair of aortic coarctation was
described by Dr. Crafoord in 1945 (5), and the ﬁrst repair at
the Mayo Clinic was in 1946. Following surgical repair of
aortic coarctation, patients experience improved survival,
with age at time of repair being the most important predictor
of survival (6). In general, signiﬁcant coarctation repair
should occur as early as possible. However, the optimal
timing of this intervention is still not clear, as it is a balance
between the risks for early and late mortality, reoperation,
and the long-term effects of hypertension.
Our objective was to review the experience of repair of
aortic coarctation over 60 years at the Mayo Clinic to identify
predictors of long-term survival, reoperation, and late
hypertension.
Methods
Institutional review board approval was obtained, which
obviated individual patient consent. From August 1946 to
Table 1 Pre-Operative Characteristics (N ¼ 819)
Characteristic Value
Age at operation
Mean  SD, yrs 17.2  13.6








Pre-operation hypertension 683 (83)
NYHA class III or IV 32 (5)
Values are mean  SD, n, or n (%).
NYHA ¼ New York Heart Association.
Abbreviations
and Acronyms
ASD = atrial septal defect
NYHA = New York Heart
Association
PFO = patent foramen ovale
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1021July 2005, 819 patients had primary operative repair of isolated
aortic coarctation. We excluded patients who had complex
left-sided cardiac lesions, interrupted aortic arch, or Shone’s
complex.
Perioperative data were collected using all available
medical records. Follow-up data were collected using all
medical records, and surveys were mailed to all patients not
known to be deceased. Survival was ascertained through
Accurint.com.
As a part of quality assurance at the Mayo Clinic, all
patients who have undergone cardiac surgery are sent
a survey on a scheduled basis. This survey includes a ques-
tion that asks whether a diagnosis of high blood pressure was
present, as well as inquiring regarding current medications
and any cardiac catheterization procedures or surgical
procedures performed. In patients in whom an intervention
is reported, medical records are requested from outside
institutions in an attempt to conﬁrm the procedure indica-
tion and type. The presence of hypertension was determined
through repeated elevated blood pressure measurements
using standard deﬁnitions of hypertension (adults: systolic
blood pressure 140 mm Hg and diastolic blood
pressure 140 mm Hg) (7) and for children as systolic and/
or diastolic blood pressure in the 95th percentile (8), the
prescription or report of antihypertensive medications, or the
self-report of a diagnosis of hypertension.
Statistical analyses were performed using SAS version 9.1
(SAS Institute Inc, Cary, North Carolina). Data are pre-
sented as mean  SD, median (range), or number (%), as
appropriate. Univariate and stepwise multivariate models
were created using Cox proportional hazards. Kaplan-Meier
curves were compared using a log-rank test. Cutoff values
were identiﬁed using an SAS macro designed to ﬁnd the
best cutoff point of a continuous variable based on a chi-
square statistic for a binomial outcome.
Results
Pre-operative characteristics are listed in Table 1. Opera-
tions included end-to-end anastomosis in 631 patients,
patch angioplasty in 73, interposition graft in 49, bypass
graft in 30, and subclavian ﬂap or other in 36. These
operations were predominantly performed prior to the 1980s
(n ¼ 612; 74.7%). The type of repair has changed over the
decades, with older patients and more complex repairs pre-
dominating in later decades (Fig. 1). Overall early mortality
(<30 days) was 2.4%. In the previous 30 years (n ¼ 225),
there were no operative deaths.
Mean follow-up was 17.4  13.9 years, with a maximum
of 59.3 years. Four hundred ﬁfty-nine patients had follow-
up >30 days, and an additional 122 surveys were returned.
Thus, data on mid- or late-term follow-up was obtained
from 70.8% of all patients.
Actuarial survival rates were 93.3%, 86.4%, and 73.5% at 10,
20, and 30 years, respectively. Mean age of death was 34.2 
20.1 years. When compared to an age- and sex-matchedpopulation, long-term survival was
decreased (p < 0.001) (Fig. 2).
Older age at repair (>20 years) and
pre-operative hypertension were
associated with decreased survival
(p < 0.001). On multivariate
analysis, only increasing age was
associated with mortality (hazard
ratio [HR]: 1.06; 95% CI: 1.04 to 1.07; p < 0.001) (Fig. 3).
Rates of freedom from re-intervention on the descending
aorta were 96.7%, 92.2%, and 89.4% at 10, 20, and 30 years,
respectively (Fig. 4). Older age (HR: 0.93; 95% CI: 0.91 to
0.96; p < 0.001) and an end-to-end anastomosis technique
(HR: 0.11; 95% CI: 0.07 to 20; p < 0.001) were indepen-
dently associated with lower re-intervention rates on the
descending aorta. Patients who had initial repair before age
1 year (n ¼ 116), had a 31.1% re-intervention rate on the
descending aorta rate at 30 years’ follow-up. The highest rate
of re-intervention on the descending aorta was in patients
who were <5 years of age at the time of operative repair
(73.3%; 95% CI: 64.1% to 83.9% at 30 years; p < 0.001;
n ¼ 192). In patients <5 years of age, simple and extended
end-to-end anastomosis technique was associated with
a decreased re-intervention rate, p < 0.013.
Rates of freedom from any cardiac reoperation were
92.8%, 85.7%, and 76.6% at 10, 20, and 30 years, respec-
tively. The majority of reoperations were for repair of
recoarctation or aortic valve disease (Table 2).
Data on follow-up regarding blood pressure status were
available from 551 patients (67.3%). Mean follow-up was
17.4  13.8 years, with a maximum of 59.3 years. The
percentages of patients with hypertension at various follow-
up intervals are presented in Fig. 5. The only predictor of
hypertension up to 5 years postoperatively was older age at
the time of operation (p < 0.001). A cutoff value of 9 years
was identiﬁed; patients 9 years of age or older at the age of
repair had signiﬁcantly more hypertension at 5 to 15 years of
follow-up (relative risk: 4.1; 95% CI: 2.1 to 8.4; p < 0.001).
Figure 1 Type of Repair, by Decade
The type of aortic coarctation repair was stratiﬁed by decade of repair. Mean  SD age, by decade, at time of operation is also included.
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1022Pre-operative hypertension was not associated with late
hypertension (p ¼ 0.06).Discussion
Our study reports late outcomes in one of the largest pub-
lished cohorts with isolated coarctation of the aorta. A
previous report on this cohort from the Mayo Clinic found
late survival of 91% at 10 years, 84% at 20 years, and 72% at
30 years (6). This was similar to our current report of survival
(93% at 10 years, 86% at 20 years, and 74% at 30 years
postoperatively). Surprisingly, improvements in operative
technique, improved medical management of hypertension,
surveillance for comorbid cardiovascular disease, andFigure 2 Overall Survival
Survival of the entire cohort compared with an age- and sex-matched Minnesota
population (p < 0.001).monitoring for complications related to the aorta have not
made as much of an impact on late survival as expected.
Surgical results. The cause of death was not known in the
majority of our patients due to the lack of autopsies performed.
One might expect that these premature deaths are likely
related to concomitant cardiovascular disease (6). A recent
study from Quebec, Canada, questioned the prevalence of
coronary artery disease in these patients later in life (9).
However, others have found that patients with successfully
repaired coarctation of the aorta have both endothelial
dysfunction (10) and impaired arterial dilation in the pre-
coarctation vascular bed (11), suggesting a possible vascular
cause of late death. Normotensive coarctation patients have
also been found to have increased left ventricular mass despite
successful aortic coarctation repair (12). This increase in
muscle mass may lead to subendocardial ischemia, late
arrhythmias, and diastolic heart failure.
There have been changes in operative strategy for aortic
coarctation over this 60-year period. Extended end to end is
the current preferred technique for repair of aortic coarctation
in neonates and children, while more complex techniques are
reserved for complicated coarctations predominantly in older
patients. The Mayo Clinic is a referral center for adult aortic
coarctations, and as such,many repair techniqueswere utilized
including ascending-to-descending bypass and aortic inter-
position grafting.
Reoperations or catheter-based re-interventions on the
descending aorta were frequent. Age <1 year at the time of
initial repair, and a repair technique other than simple or
extended end-to-end anastomosis, were independently
associated with the need for reoperation or re-intervention
on the aorta. Younger age at operation has been reported
as a risk factor for recoarctation and the need for late
Figure 3 Survival, by Age
Survival, stratiﬁed by age20 or >20 years at time of initial operation (p < 0.001).
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1023re-intervention in several studies (13,14). It is likely that in
small children, the technical challenge of resection of all
periductal tissue, as well as the small anastomosis size, may
lead to an increased risk for late recoarctation. Patients who
are diagnosed and present at a young age may also have more
severe coarctation and therefore are also predisposed to late
vascular complications. In general, an extended end-to-end
anastomosis is the preferred type of repair. Patients who
received other types of repairs such as subclavian ﬂap or
ascending-to-descending aortic bypass are more likely to
have longer segments of stenosis or arch involvement.
Unfortunately, not all forms of coarctation of the aorta are
amenable to an end-to-end anastomosis.
In this cohort, a large number of other cardiovascular
procedures were performed later in life, including aortic
valve procedures, ascending aortic procedures, coronaryFigure 4 Reoperation on the Descending Aorta
Reoperation on the descending aorta following coarctation repair. Patients
who died <30 days after the initial operation were excluded.artery bypass grafting, and mitral valve procedures. These
data further underline the importance of ongoing follow-up
in patients with aortic coarctation, and that repair of the
coarctation does not mean a “cure.” We recommend annual
clinical evaluation to assess blood pressure. Regular cardiac
imaging is also recommended to assess the aorta (ascending
aorta, arch, and descending aorta), valves, and ventricles.
These patients should be followed up by physicians who
have expertise in congenital heart disease.
In the most recent 225 patients, there were no operative
deaths in our series. By comparison, Birmingham Children’s
Hospital, Birmingham, Alabama, reported a 1% mortality
(15), and Children’s Memorial Hospital, Chicago, Illinois,
reported a 2% mortality (16) in surgical repair of aortic
coarctation. Our results conﬁrm that surgical correction of
isolated aortic coarctation can be safely performed and any
newer technologies, such as catheter-based intervention,
should be held to these high standards.
Blood pressure data. Data on blood pressure readings or
a self-report of hypertension was available in over 70% of
patients. Older age at the time of repair was independently
associatedwith late hypertension. Patients with repair of aortic
coarctation before age 9 years had less hypertension at 5 to 15
years of follow-up. However, pre-operative hypertension was
not associatedwith late hypertension.Thepresence anddegree
of hypertension in native aortic coarctation did not impact
prognosis following repair, suggesting that the vascular system
is adversely affected in patients with unrepaired coarctation
and that intervention is advisable for important coarctation at
the time of diagnosis.
Timing of intervention. Identifying the ideal time for
repair of aortic coarctation remains challenging, and indi-
cations for intervention were reﬁned during the study period.
Our patient population represented referral bias, including
more adults than in most other series. We refer patients with
severe coarctation for intervention when the diagnosis is
made, regardless of age. Survival was not reduced until
patients had reached adulthood (>20 years). Patients who
had a repair of aortic coarctation at younger than 5 years had
the greatest risk for reoperation. Patients who were older
than 9 years of age at the time of repair had a greater prev-
alence of residual hypertension, suggesting that repair may
be best performed between the ages of 5 and 9 years, unless
a patient presents with severe symptoms. This is similar to
a report from the Netherlands wherein children who
were <10 years of age at the time of repair had the best
survival (97% at 30 years post surgical repair) (14).
Our study spans over 60 years of operative history at the
Mayo Clinic, and there have been many developments in
diagnostic techniques, medical options, and interventional
procedures. These factors must be considered when inter-
preting our results. In addition, we included only patients
who underwent surgical coarctation repair. Recent American
Heart Association guidelines on percutaneous management
of congenital cardiac disorders included aortic coarctation
or recoarctation, irrespective of patient age, as a Class I
Table 2 All Reoperations and Re-Interventions (n ¼ 124)




Aortic valve replacement 52
Aortic valve repair 17
Coronary artery bypass grafting 13
Mitral valve replacement 10
Ascending aneurysm repair 8
Mitral valve repair 6
Descending aortic aneurysm 5
Aortic dissection 2
Other (maze, ASD/PFO, pericardiectomy,
subclavian aneurysm, subaortic stenosis)
9
Total 175
ASD/PFO ¼ atrial septal defect/patent foramen ovale.
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1024indication for catheter-based interventions (17). While we
also perform catheter-based interventions in patients with
aortic coarctation and recoarctation, these patients were not
included in this series.
Study limitations. Due to the observational nature of this
study, follow-up interval and availability of blood pressure
data varied. We were able to identify the presence or absence
of late hypertension in two-thirds of our patients, but we
were unable to determine other important factors, including
the type and number of medical therapies that these patients
with late hypertension required. We utilized direct blood
pressure measurements when available, although we also
used a self-report of hypertension. Previous work from the
Mayo Clinic (18) reported in 25,415 patients that the
sensitivity of a patient-reported diagnosis of high bloodFigure 5 Hypertension Pre- and Post-Repair
Comparison of hypertension pre- and post-operatively at various time intervals
of follow-up (all, p < 0.001).pressure was 73.2% (95% CI: 72.1% to 74.2%) and that the
speciﬁcity was 94.6% (95% CI: 94.3% to 94.9%).
As well, due to the retrospective nature of this study, we
may have not identiﬁed all re-intervention events, and as
such, our estimates, while consistent with previously pub-
lished rates, including those from our institution (6,13), may
be low. We are also unable to comment on the prevalence of
coronary artery disease, as we considered only those patients
who required re-intervention such as angioplasty or coronary
artery bypass grafting. This likely resulted in an underesti-
mation of coronary artery disease in this population.
Conclusions
Surgical repair of aortic coarctation can be performed with
minimal mortality. Long-term outcomes demonstrate that
surgery is not a cure; patients have high rates of hyperten-
sion, need for re-intervention, and decreased survival. These
results stress the importance of lifelong informed follow-up
and aggressive identiﬁcation and treatment of sequelae in
patients with aortic coarctation.Reprint requests and correspondence: Dr. Harold M. Burkhart,
Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905.
E-mail: burkhart.harold@mayo.edu.REFERENCES
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